23 results on '"Bergmann, Martin W."'
Search Results
2. The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION
3. Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial.
4. Treatment With an Interatrial Shunt in Heart Failure
5. Positionspapier „Schlafmedizin in der Kardiologie“, Update 2021
6. Heart failure with preserved ejection fraction in patients with moderate/severe aortic stenosis: what harms our patients most?
7. Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure
8. Limitations in Contemporary Pharmacological Stroke Prevention Therapies in Atrial Fibrillation: A Descriptive Literature Review
9. Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection—Insights from the CORONA Germany study
10. Improving Left Atrial Appendage Closure
11. Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fraction
12. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure
13. Left atrial appendage closure in end‐stage renal disease and hemodialysis: Data from a German multicenter registry
14. Atrial Giant Cell Myocarditis as a Cause of Heart Failure
15. Sex‐related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.
16. Effect of allogeneic adipose tissue‐derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction – the SCIENCE trial.
17. Intramyocardial injections of erythropoietin-analogue C.E.R.A. in ischemic cardiomyopathy: the ALSTER C.E.R.A. trial
18. Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients—Results from the CORONA Germany Study
19. Heart failure with preserved ejection fraction in patients with moderate/severe aortic stenosis: what harms our patients most?
20. True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION Registry.
21. Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial.
22. ALSTER-TAVR 2024: clinical results at one year following optimized self-expanding, transcatheter aortic valve peplacement employing the cusp-overlay technique.
23. Heart failure with preserved ejection fraction in patients with moderate/severe aortic stenosis: what harms our patients most?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.